IDEXX Laboratories Inc (IDXX) Common Stock USD0.10
Sell:$412.26Buy:$412.62
$3.23
(0.79%)
NASDAQ:
1.03%
1.03%Market closed | Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:$412.26
Buy:$412.62
Change:$3.23
(0.79%)
$3.23
(0.79%)Market closed | Prices delayed by at least 15 minutes
Sell:$412.26
Buy:$412.62
Change:$3.23
(0.79%)
$3.23
(0.79%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 27 November 2024 | Sophie V VandebroekIndependent Director | Sell Regular sell transaction (market) | 344 | $420.44 | $144,629.64 | 905 |
| 6 September 2024 | Margaret Anne SzostakIndependent Director | Sell Regular sell transaction (market) | 500 | $469.37 | $234,686.15 | 0 |
| 1 September 2024 | Michael SchreckExecutive Vice President | Sell Tax related | 48 | $481.33 | $23,103.84 | 913 |
| 1 September 2024 | Martin Alexander SmithCTO | Sell Tax related | 5 | $481.33 | $2,406.65 | 510 |
| 5 August 2024 | Jonathan J (Jay) MazelskyPresident/CEO | Sell Tax related | 170 | $455.08 | $77,363.60 | 81,733 |
| 5 August 2024 | Brian P. McKeonCFO | Sell Tax related | 117 | $455.08 | $53,244.36 | 30,932 |
| 17 May 2024 | Bruce L ClaflinIndependent Director | Sell Regular sell transaction (market) | 200 | $540.80 | $108,160.00 | 161 |
| 6 March 2024 | James F. (Jim) PolewaczykChief Level Officer | Sell Option/Award related | 4,134 | $557.94 | $2,306,528.09 | 14,681 |
| 6 March 2024 | James F. (Jim) PolewaczykChief Level Officer | Sell Option/Award related | 3,290 | $558.88 | $1,838,722.44 | 11,391 |
| 6 March 2024 | James F. (Jim) PolewaczykChief Level Officer | Sell Option/Award related | 680 | $559.33 | $380,345.62 | 10,711 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 7 February 2024 | Brian P. McKeonCFO | Sell Option/Award related | 7,128 | $571.84 | $4,076,061.98 | 30,399 |
| 7 February 2024 | Brian P. McKeonCFO | Sell Option/Award related | 5,675 | $570.97 | $3,240,253.05 | 37,527 |
| 7 February 2024 | Jonathan J (Jay) MazelskyPresident/CEO | Sell Option/Award related | 5,356 | $571.71 | $3,062,060.55 | 85,891 |
| 7 February 2024 | Jonathan J (Jay) MazelskyPresident/CEO | Sell Option/Award related | 4,124 | $572.53 | $2,361,094.34 | 81,767 |
| 6 March 2024 | James F. (Jim) PolewaczykChief Level Officer | Sell Option/Award related | 4,134 | $557.94 | $2,306,528.09 | 14,681 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.